---
title: "Wells Fargo maintains BeOne Medicines at Overweight, raises price target to $435 from $400"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304659494.md"
description: "Wells Fargo maintained BeOne Medicines at Overweight and raised its price target to $435 from $400, an 8.8% increase.The price target implies an upside of 56.1% from the Nov 6 close of $278.60.Explore more price target data and ratings for BeOne Medicines on the , and track all previous and future analyst recommendations in the dedicated News Flow.DisclaimerSelect reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice."
datetime: "2026-11-06T14:51:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304659494.md)
  - [en](https://longbridge.com/en/news/304659494.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304659494.md)
generator: "portal-rs"
---

# Wells Fargo maintains BeOne Medicines at Overweight, raises price target to $435 from $400

Wells Fargo maintained BeOne Medicines at Overweight and raised its price target to $435 from $400, an 8.8% increase.

The price target implies an upside of 56.1% from the Nov 6 close of $278.60.

Explore more price target data and ratings for BeOne Medicines on the , and track all previous and future analyst recommendations in the dedicated News Flow.

**Disclaimer**

Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)

## Related News & Research

- [BeOne Medicines: Five solid-tumor programs advance as strong cash flow funds continued pipeline investment](https://longbridge.com/en/news/305810947.md)
- [Why BeOne Medicines Stock Is In Focus After Earnings Beat And Raised Guidance](https://longbridge.com/en/news/304730912.md)
- [Will Revenue Outlook Cut Change Lululemon Stock's Narrative](https://longbridge.com/en/news/305993397.md)
- [How did Coinbase stop deepfake Elon Musk’s promise to double your crypto?](https://longbridge.com/en/news/306049317.md)
- [Is ServiceNow (NOW) Trading At Too High A Premium For Earnings?](https://longbridge.com/en/news/306039339.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**